Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
about
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationPharmacological cardioversion for atrial fibrillation and flutterAtrial fibrillation in heart failure: what should we do?Catheter ablation versus rate control for atrial fibrillation: what have we learnt from the ARC-HF trial?Atrial fibrillation in heart failure: an innocent bystander?2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?Antiarrhythmic drugs for atrial fibrillation.Atrial tachyarrhythmia in adult congenital heart diseaseComparison of the effects of DC031050, a class III antiarrhythmic agent, on hERG channel and three neuronal potassium channels.Selective molecular potassium channel blockade prevents atrial fibrillationDronedarone in patients with congestive heart failure: insights from ATHENA.Advances in the Pharmacological Treatment of Atrial Fibrillation.Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillationDofetilide: a new class III antiarrhythmic agent.Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trialEfficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter.Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study.Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatmentInternal medicine physicians' perceptions regarding rate versus rhythm control for atrial fibrillation.Atrial fibrillation in patients with congestive heart failure.Novel pharmacological targets for the rhythm control management of atrial fibrillation.Overview of the management of atrial fibrillation: what is the current state of the art?Atrial fibrillation in heart failure: prognostic significance and management.Atrial fibrillation after cardiac surgery: pathophysiology and treatment.Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.Management of atrial fibrillation in patients with congestive heart failure.New antiarrhythmic agents for atrial fibrillation and atrial flutter.Antiadrenergic therapy in the control of atrial fibrillation.Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits.Novel anti-arrhythmic medications in the treatment of atrial fibrillationModern management of arrhythmias.Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.Atrial fibrillation in patients with heart failure: Role of catheter ablation therapies.
P2860
Q24187110-C887C242-EE1E-49AB-8F7A-13E0512E80A3Q24197643-4A3EA2C9-34A0-4298-A433-0536EFE0DDA5Q24243067-D3387AE3-EA9A-41A0-B29B-CC2326FB2CDBQ24246997-07723F01-C3C6-4ED5-873A-847DA3755611Q26784426-08DB5A85-438B-4463-A569-F9DD52DED3D0Q27002352-343698AE-BE1A-41B2-BABC-B8A4D9F56591Q27010588-9DADE508-0DB4-4C35-AEFB-AAF76EE54362Q27341873-63847D18-947F-49A6-873D-78F009EBE4D5Q30653045-40BD2CC1-CA6F-4D7F-8123-777A89EEB228Q33553902-3628E87B-F17F-4DE3-A193-0DE1909C9A2EQ33585592-B0F61704-4914-4987-865B-3B02FD91911CQ33821199-8702C533-3BF0-4288-9242-85A9F1BACE67Q33854123-BFEB7007-35C6-4C26-805B-ED48242156A1Q33858857-76AF78C9-EF0C-4D0B-BC7E-D780944B4DEEQ33943789-45E84A22-8CD9-4BAD-AA26-ADDFF794FD00Q33992727-039DFBE1-8945-46F8-A5FA-34F71C672F59Q34383573-29F59E81-DD0E-4762-9C20-330F04CC1F90Q34523170-DB709CD3-A74D-4459-B841-C7498F59F874Q34594440-A9CF09C4-E6DC-445A-971E-EB18DD0002EEQ34626361-00A385A5-144F-4B7F-B4A4-FCD04ECB30A2Q34805855-1960E78C-15A9-4DB7-8D20-07A6B909D5A4Q35028720-57A95472-311F-4CA7-8A67-0719A7D8AF6CQ35143132-769C3F56-9CF9-473A-B82D-2605C646FB6BQ35177830-99A3EC6B-6354-4F32-8CA3-03A22C0F04C4Q35180923-02182704-55B1-48B9-B621-1A1EAF023B3AQ35197762-03E5FB88-9134-4986-B9EE-8259FFC995A5Q35489060-86BEDEE2-3336-4CC0-B737-99778323AD66Q35684050-773B3FD1-E2A2-46DC-B6CE-794C2F5A3498Q35684055-9DC714B0-497D-4AF4-872D-59B09B543369Q35891042-AFBFE356-12C0-41BE-8649-FBD315F3C534Q36031425-64B8FF2B-8E7B-44B9-A804-F285755142BFQ36077788-159F447E-7640-4B44-B8C3-D4F3F7C3F5B8Q36150617-9537D7A2-CD00-4F4A-B5E7-90F71353111DQ36167685-600550BD-ADAC-4BA2-BC16-7E1C7FD857B8Q36216795-0CABD2E5-F6BD-4BFD-A3AD-4E87DFCD389DQ36382379-7D36A19D-C488-4E86-A3EE-19D437698138Q36388570-A7409176-63DF-40F1-85C0-152F322C3813Q36456002-D1097C5F-E387-4E1C-A2C2-9D4C2FAC6EB5Q36535510-4B6559BD-4892-4FE6-859C-C1180BBF76B0Q36768493-B4F54A48-C023-4D8F-9460-39C80C98CCC0
P2860
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Efficacy of dofetilide in the ...... dofetilide (diamond) substudy.
@en
Efficacy of dofetilide in the ...... ia and mortality on dofetilide
@nl
type
label
Efficacy of dofetilide in the ...... dofetilide (diamond) substudy.
@en
Efficacy of dofetilide in the ...... ia and mortality on dofetilide
@nl
prefLabel
Efficacy of dofetilide in the ...... dofetilide (diamond) substudy.
@en
Efficacy of dofetilide in the ...... ia and mortality on dofetilide
@nl
P2093
P356
P1433
P1476
Efficacy of dofetilide in the ...... dofetilide (diamond) substudy.
@en
P2093
P304
P356
10.1161/01.CIR.104.3.292
P407
P577
2001-07-01T00:00:00Z